ReviewClinical journal of the American Society of Nephrology : CJASN2014

Is newer safer? Adverse events associated with first-line therapies for ANCA-associated vasculitis and lupus nephritis.

Jonathan Hogan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.